Keryx Biopharmaceuticals, Inc. KERX is expected to report first-quarter 2017 results on May 4. Last quarter, the company missed expectations by 18.52%. In fact, Keryx’s performance over the last four quarters has been disappointing. The …
Keryx Biopharmaceuticals Inc. (KERX) announced Monday morning that a supply interruption ... Shares finished with a loss of 2.64 at $4.72 on the second highest volume of the year. The stock sank to a 3-month low and fell below its 50 …
The stock has increased 35 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KERX
Keryx Biopharmaceuticals, Inc. KERX is expected to report second-quarter 2016 results on Aug 3. Keryx’s track record has been disappointing so far. Over the four trailing quarters, the company posted an average negative earnings surprise …